Wintrust Investments’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-932
Closed -$30K 499
2024
Q3
$30K Sell
932
-9,106
-91% -$285K 0.02% 404
2024
Q2
$301K Buy
10,038
+2,657
+36% +$80.6K 0.02% 377
2024
Q1
$235K Sell
7,381
-74,753
-91% -$2.3M 0.02% 420
2023
Q4
$2.45M Sell
82,134
-1,048
-1% -$28.7K 0.24% 85
2023
Q3
$2.28M Sell
83,182
-2,018
-2% -$58.7K 0.24% 89
2023
Q2
$2.54M Sell
85,200
-6,330
-7% -$185K 0.25% 84
2023
Q1
$2.67M Buy
91,530
+370
+0.4% +$10.8K 0.34% 57
2022
Q4
$2.63M Sell
91,160
-580
-0.6% -$16.2K 0.34% 59
2022
Q3
$2.31M Buy
91,740
+4,140
+5% +$113K 0.29% 69
2022
Q2
$2.35M Buy
87,600
+1,690
+2% +$47.9K 0.28% 61
2022
Q1
$2.63M Buy
85,910
+140
+0.2% +$4.19K 0.25% 66
2021
Q4
$2.75M Buy
85,770
+5,740
+7% +$175K 0.26% 68
2021
Q3
$2.39M Buy
+80,030
New +$2.46M 0.32% 57

Other funds holding RSPH

Wintrust Investments's RSPH Position: Q4 2024 in Review

Wintrust Investments sold out of Invesco S&P 500 Equal Weight Health Care ETF (RSPH) in Q4 2024, closing a stake of 932 shares — an estimated $30K sold.

Wintrust Investments first reported a position in RSPH in Q3 2021 and held it in 13 quarters. The position peaked at $2.75M in Q4 2021. 191 funds tracked by Wall St. Rank hold RSPH as of Q4 2024.

  • Wintrust Investments reported no remaining Invesco S&P 500 Equal Weight Health Care ETF position as of Q4 2024 after selling out during the quarter.
  • Wintrust Investments sold 932 Invesco S&P 500 Equal Weight Health Care ETF shares in Q4 2024, an estimated $30K.
  • Wintrust Investments first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q3 2021 and held it in 13 quarters.
  • Wintrust Investments's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $2.75M in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.